Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)

Accolade Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Net Income	-	-166.39	-87.54	-181.13	-102.11	-57.93
Depreciation & Amortization	-	2	2.13	2.37	2.37	2.76
Other Operating Activities	-	4.95	41.27	296.94	-1.52	-18.19
Change in Accounts Receivable	-	-127.43	-11.23	176.03	553.58	-570.28
Change in Inventory	-	348.28	-227.59	382.28	-372.8	-127.18
Change in Accounts Payable	-	1.62	-139.24	-287.38	-6.53	437.66
Change in Unearned Revenue	-	-	-	-	-	-13.84
Change in Other Net Operating Assets	-	45.9	1.05	-271.35	267.8	26.04
Operating Cash Flow	-	108.92	-421.15	117.77	340.79	-320.96
Operating Cash Flow Growth	-	-	-	-65.44%	-	-
Capital Expenditures	-	-	-	-	-0.01	-0.25
Other Investing Activities	-	4.62	5.31	6.69	9.13	7.23
Investing Cash Flow	-	4.62	5.31	6.69	9.12	6.98
Short-Term Debt Issued	-	-	505.92	242.55	-	322.22
Total Debt Issued	-	-	505.92	242.55	-	322.22
Short-Term Debt Repaid	-	-76.6	-	-	-291.84	-
Total Debt Repaid	-	-76.6	-	-	-291.84	-
Net Debt Issued (Repaid)	-	-76.6	505.92	242.55	-291.84	322.22
Other Financing Activities	-	-70.52	-55.92	-364.58	-52.31	-15.15
Financing Cash Flow	-	-147.12	450	-122.03	-344.14	307.07
Miscellaneous Cash Flow Adjustments	-	-	-	-	-	-1
Net Cash Flow	-	-33.57	34.16	2.43	5.77	-7.9
Free Cash Flow	-	108.92	-421.15	117.77	340.79	-321.21
Free Cash Flow Growth	-	-	-	-65.44%	-	-
Free Cash Flow Margin	-	24.42%	-53.73%	13.80%	50.99%	-38.40%
Free Cash Flow Per Share	-	2.52	-9.75	2.73	7.89	-7.44
Cash Interest Paid	-	70.49	55.92	47.77	47.42	20.04
Levered Free Cash Flow	-	125.24	-476.84	-172.27	367.5	-354.34
Unlevered Free Cash Flow	-	168.76	-444.91	-145	392.89	-345.23
Change in Working Capital	-	268.37	-377.01	-0.42	442.06	-247.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.